HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 54 filers reported holding HAEMONETICS CORP MASS in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $134,463 | +2.0% | 155,000 | 0.0% | 0.01% | +25.0% |
Q2 2023 | $131,890 | +0.3% | 155,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $131,514 | +102645.3% | 155,000 | 0.0% | 0.00% | -20.0% |
Q4 2022 | $128 | -99.9% | 155,000 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $123,000 | +1.7% | 155,000 | 0.0% | 0.01% | +25.0% |
Q2 2022 | $121,000 | – | 155,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 18,000,000 | $15,705,000 | 1.15% |
Context Capital Management, LLC | 14,558 | $12,660 | 1.02% |
Quaero Capital S.A. | 1,200,000 | $1,042,440 | 0.99% |
READYSTATE ASSET MANAGEMENT LP | 22,200,000 | $19,369,500 | 0.97% |
DeepCurrents Investment Group LLC | 24,371,000 | $21,212,517 | 0.92% |
ADVENT CAPITAL MANAGEMENT /DE/ | 39,904,000 | $34,816,240 | 0.81% |
SSI INVESTMENT MANAGEMENT LLC | 10,872,000 | $9,431,462 | 0.77% |
Empyrean Capital Partners, LP | 13,500,000 | $11,696,959 | 0.72% |
MACKAY SHIELDS LLC | 29,294,000 | $25,825,110 | 0.71% |
Aequim Alternative Investments LP | 20,500,000 | $17,886,250 | 0.68% |